Not logged in
  Home   Markets   Shares   Funds   Portfolio   Toolbox   Charting   Alerts   Directory   
 Admin   

Wed 17 Jul 2002, 0:00 Mb Technologies - Proposed Management Buy-out Of M
MB Technologies - Proposed Management Buy-Out Of MB Technologies and Further    
Cautionary Announcement                                                         
MB Technologies Limited                                                         
(Incorporated in the Republic of South Africa)                                  
(Registration number 1998/008964/06)                                            
Share code: MBT   ISIN: ZAE000015996                                            
("MB Technologies" or "the Company")                                            
PROPOSED MANAGEMENT BUY-OUT OF MB TECHNOLOGIES AND FURTHER CAUTIONARY           
ANNOUNCEMENT                                                                    
The Board of MB Technologies received a letter on 17 July 2002 from Clidet No.  
408 (Proprietary) Limited ("Clidet"), a special purpose vehicle backed by a     
consortium (comprising founder shareholders, namely Messrs LC Baxter and MJ     
McGrath, senior management and Central Holdings Limited or its nominee)         
("Consortium") and Absa Bank Limited ("Absa"), expressing its, or its nominee`s,
firm intention to, either:                                                      
- make an offer to acquire all of the issued ordinary shares of MB Technologies 
not already owned by  the consortium, for a cash consideration equivalent to 140
cents per MB Technologies share ("transaction"). The transaction shall be       
implemented by Clidet proposing a scheme of arrangement ("the scheme") in terms 
of section 311 of the Companies Act, 1973 ("the Act") between MB Technologies   
and its shareholders other than the Consortium; or                              
- in the event of the scheme not being implemented, making an offer to all MB   
Technologies shareholders other than the Consortium in terms of section 440 of  
the Act to acquire their MB Technologies shares for a cash consideration        
equivalent to 140 cents per MB Technologies share ("offer"); or                 
- make an offer to acquire all the assets and liabilities of MB Technologies in 
terms of section 228 of the Act ("the asset disposal"). A capital distribution  
dividend of 140 cents per ordinary MB Technologies share will be paid to        
shareholders as an advance distribution in a members` voluntary winding-up of   
the company;                                                                    
(collectively "the proposals").                                                 
The Consortium currently owns approximately 53,35% of the shares of MB          
Technologies.                                                                   
The proposals are subject, inter alia, to:                                      
- Clidet conducting a due diligence of MB Technologies and Clidet confirming    
that it is satisfied with the outcome of the due diligence, which is estimated  
to take approximately 25 business days;                                         
- Clidet entering into management, shareholder and loan agreements with the     
Consortium;                                                                     
- In the event of the scheme being implemented, Clidet acquiring all the issued 
shares in MB Technologies other than those held by the Consortium.  This will   
require the requisite shareholder approvals being obtained and the scheme being 
implemented or the offer being accepted by at least 90% of shareholders to whom 
it is made, should the offer become operative;                                  
- In the event of the asset disposal being implemented, the conclusion of a     
formal disposal agreement between Clidet and MB Technologies; and               
- the requisite regulatory approvals and consents (including, without           
limitation, the Competition Authorities, JSE Securities Exchange South Africa   
and the Securities Regulation Panel).                                           
The letter from Clidet referred to above was accompanied by a letter from Clidet
confirming that Clidet has satisfied the SRP that it has sufficient financial   
resources to satisfy its obligations in terms of the proposals.                 
A further announcement containing detailed terms and financial effects of the   
proposals will be published as soon as possible and shareholders are therefore  
advised to continue exercising caution in dealing in their MB Technologies      
shares. Deloitte & Touche have been appointed as external advisor to review the 
terms of the proposals and their opinion will be included in the circular that  
will be mailed to shareholders in due course.                                   
Sandton                                                                         
17 July 2002                                                                    
Corporate advisor   Sponsor              Legal advisor                          
ACMB                Merrill Lynch        Cliffe Dekker                          
Reporting                                Independent advisor                    
accountants                              to the minorities                      
Deloitte & Touche                                                               
                                         Deloitte & Touche                      
Date: 17/07/2002 05:52:54 PM Produced by the JSE SENS Department                



Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
Other Profile Group sites: FundsData Online (unit trust data)  |  Profile Group corporate site
[  Terms of Use |  Privacy Policy |  PAIA manual |  FAQs/Help |  Site Map |  © Copyright Reserved 2026  ]
  


Powered by ProfileData

Profile Mobile App Google Play Store Apple App Store


Follow us on: